ICH-Protocol Template

May 12, 2008 · Recently, the Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial, a large multicenter Phase II study comparing two doses of autologous skeletal myoblasts to placebo in patients undergoing CABG, was terminated early by the DSMB on a futility basis, with virtually no chance that either the high-dose group or the low-dose group ... ................
................